Literature DB >> 32029137

Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review.

Jeffrey I Mechanick1, Michael E Farkouh2, Jonathan D Newman3, W Timothy Garvey4.   

Abstract

In the second part of this JACC State-of-the-Art Review, an early and sustainable preventive care plan is described for cardiometabolic-based chronic disease. This plan can improve cardiometabolic health by targeting early mechanistic events to decrease the risk for certain cardiovascular diseases (e.g., coronary heart disease, heart failure, and atrial fibrillation). Included are various prevention modalities, intensive lifestyle interventions, pharmacotherapy and cardiovascular outcome trial evidence, and bariatric/metabolic procedures. A tactical approach of implementing published clinical practice guidelines/algorithms for early behavioral, adiposity, and dysglycemia targeting is emphasized, as well as relevant educational and research implications.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adipokines; adiposity; atherosclerosis; atrial fibrillation; cardiometabolic; cardiomyopathy; cardiovascular; chronic disease; dysglycemia; health; insulin; obesity; resistance; type 2 diabetes

Mesh:

Year:  2020        PMID: 32029137      PMCID: PMC8168371          DOI: 10.1016/j.jacc.2019.11.046

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  157 in total

1.  Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.

Authors:  Hassan Rahmoune; Paul W Thompson; Joanna M Ward; Chari D Smith; Guizhu Hong; John Brown
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

Review 2.  Metabolic Surgery: Weight Loss, Diabetes, and Beyond.

Authors:  Manan Pareek; Philip R Schauer; Lee M Kaplan; Lawrence A Leiter; Francesco Rubino; Deepak L Bhatt
Journal:  J Am Coll Cardiol       Date:  2018-02-13       Impact factor: 24.094

Review 3.  Diagnostic imaging in the management of patients with metabolic syndrome.

Authors:  Seo Rin Kim; Lilach O Lerman
Journal:  Transl Res       Date:  2017-11-22       Impact factor: 7.012

4.  SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Authors:  Thomas A Zelniker; Stephen D Wiviott; Itamar Raz; Kyungah Im; Erica L Goodrich; Marc P Bonaca; Ofri Mosenzon; Eri T Kato; Avivit Cahn; Remo H M Furtado; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Marc S Sabatine
Journal:  Lancet       Date:  2018-11-10       Impact factor: 79.321

Review 5.  Origins of lifetime health around the time of conception: causes and consequences.

Authors:  Tom P Fleming; Adam J Watkins; Miguel A Velazquez; John C Mathers; Andrew M Prentice; Judith Stephenson; Mary Barker; Richard Saffery; Chittaranjan S Yajnik; Judith J Eckert; Mark A Hanson; Terrence Forrester; Peter D Gluckman; Keith M Godfrey
Journal:  Lancet       Date:  2018-04-16       Impact factor: 79.321

6.  Bariatric surgery reduces incidence of atrial fibrillation: a propensity score-matched analysis.

Authors:  Kevin T Lynch; J Hunter Mehaffey; Robert B Hawkins; Taryn E Hassinger; Peter T Hallowell; Jennifer L Kirby
Journal:  Surg Obes Relat Dis       Date:  2018-11-24       Impact factor: 4.734

7.  Low cardiorespiratory fitness and coronary artery calcification: Complementary cardiovascular risk predictors in asymptomatic type 2 diabetics.

Authors:  Barak Zafrir; Mohanad Azaiza; Tamar Gaspar; Idit Dobrecky-Mery; Mali Azencot; Basil S Lewis; Ronen Rubinshtein; David A Halon
Journal:  Atherosclerosis       Date:  2015-06-18       Impact factor: 5.162

8.  Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women.

Authors:  Nikola Drca; Alicja Wolk; Mats Jensen-Urstad; Susanna C Larsson
Journal:  Heart       Date:  2015-05-27       Impact factor: 5.994

9.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

Review 10.  Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Jennifer S Lin; Corinne V Evans; Eric Johnson; Nadia Redmond; Erin L Coppola; Ning Smith
Journal:  JAMA       Date:  2018-07-17       Impact factor: 56.272

View more
  14 in total

Review 1.  Cardiometabolic-based chronic disease: adiposity and dysglycemia drivers of heart failure.

Authors:  Eduardo Thadeu de Oliveira Correia; Jeffrey I Mechanick; Letícia Mara Dos Santos Barbetta; Antonio José Lagoeiro Jorge; Evandro Tinoco Mesquita
Journal:  Heart Fail Rev       Date:  2022-04-04       Impact factor: 4.214

Review 2.  The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern Version.

Authors:  Osama Hamdy; Saud Al Sifri; Mohamed Hassanein; Mohammed Al Dawish; Raed A Al-Dahash; Fatheya Alawadi; Nadim Jarrah; Hajar Ballout; Refaat Hegazi; Ahmed Amin; Jeffrey I Mechanick
Journal:  Front Nutr       Date:  2022-06-13

Review 3.  Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease.

Authors:  Jianguo Lin; Jinlong Duan; Qingqing Wang; Siyu Xu; Simin Zhou; Kuiwu Yao
Journal:  Front Cardiovasc Med       Date:  2022-06-17

4.  Genetic Thyrotropin Regulation of Atrial Fibrillation Risk Is Mediated Through an Effect on Height.

Authors:  Mingjian Shi; Ali M Manouchehri; Christian M Shaffer; Nataraja Sarma Vaitinadin; Jacklyn N Hellwege; Joe-Elie Salem; Lea K Davis; Jill H Simmons; Dan M Roden; M Benjamin Shoemaker; Jane F Ferguson; Jonathan D Mosley
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

5.  Non-alcoholic Fatty Liver Disease, Cardio-metabolic Syndrome and Hypertension: One Concept Fits Multi-systemic Presentations.

Authors:  Mi Jeong Kim
Journal:  Korean Circ J       Date:  2020-08       Impact factor: 3.243

6.  TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial.

Authors:  Deepa Joshi; Prashant Gj; Shohini Ghosh; Anookh Mohanan; Shashank Joshi; Viswanathan Mohan; Subhankar Chowdhury; Chaitanya Dutt; Nikhil Tandon
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-25       Impact factor: 3.168

Review 7.  Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries.

Authors:  Chaitanya Dutt; Joao Eduardo Nunes Salles; Shashank Joshi; Tiny Nair; Subhankar Chowdhury; Ambrish Mithal; Viswanathan Mohan; Ravi Kasliwal; Satyawan Sharma; Jan Tijssen; Nikhil Tandon
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-16       Impact factor: 3.168

8.  The Combined Effects of Television Viewing and Physical Activity on Cardiometabolic Risk Factors: The Kardiovize Study.

Authors:  Geraldo A Maranhao Neto; Iuliia Pavlovska; Anna Polcrova; Jeffrey I Mechanick; Maria M Infante-Garcia; Jose Medina-Inojosa; Ramfis Nieto-Martinez; Francisco Lopez-Jimenez; Juan P Gonzalez-Rivas
Journal:  J Clin Med       Date:  2022-01-22       Impact factor: 4.241

9.  National trends in insulin resistance and β-cell dysfunction among adults with prediabetes: NHANES 2001-2016.

Authors:  Hao-Jie Zhang; Xiao Tan; Ning-Jian Wang
Journal:  Chronic Dis Transl Med       Date:  2021-01-07

Review 10.  Coronavirus and Cardiometabolic Syndrome: JACC Focus Seminar.

Authors:  Jeffrey I Mechanick; Robert S Rosenson; Sean P Pinney; Donna M Mancini; Jagat Narula; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2020-10-27       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.